Page last updated: 2024-08-24

pyrazolo(3,4-d)pyrimidine and Experimental Hepatoma

pyrazolo(3,4-d)pyrimidine has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gromnicka, A; Havlíček, L; Jorda, R; Kryštof, V; Strnad, M; Ulrich, M; Vollmar, AM; Zahler, S; Zhang, S	1

Other Studies

1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Experimental Hepatoma

Article	Year
Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffold. British journal of pharmacology, 2016, Volume: 173, Issue:17 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase 5; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms, Experimental; Mice; Pyrazoles; Pyrimidines; Structure-Activity Relationship	2016

Article

Year

Anti-angiogenic effects of novel cyclin-dependent kinase inhibitors with a pyrazolo[4,3-d]pyrimidine scaffold.

British journal of pharmacology, 2016, Volume: 173, Issue:17

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase 5; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms, Experimental; Mice; Pyrazoles; Pyrimidines; Structure-Activity Relationship

2016